Hepatocellular carcinoma: early-stage management challenges

Area of Science:

• Hepatology
• Oncology
• Gastroenterology

Background:

• Hepatocellular carcinoma (HCC) is a significant cause of cancer mortality with rising incidence.
• Effective surveillance and early-stage treatment are critical for improving patient outcomes.
• Current screening faces challenges due to noncompliance and underdiagnosis in chronic liver disease patients.

Purpose of the Study:

• To review current strategies for hepatocellular carcinoma (HCC) surveillance.
• To discuss the evolving landscape of early-stage HCC treatment options.
• To highlight recent advancements in HCC management and future research directions.

Main Methods:

• Comprehensive literature review of HCC surveillance guidelines and screening practices.
• Analysis of current and emerging therapeutic modalities for early-stage HCC.
• Evaluation of recent advancements in liver transplantation and surgical indications.

Main Results:

• HCC surveillance guidelines exist but face implementation barriers.
• Early-stage HCC treatment is complex, with expanding surgical indications and improved efficacy of established therapies like transarterial chemoembolization and radiofrequency ablation.
• Liver transplantation criteria have broadened, yielding comparable outcomes.

Conclusions:

• Improved adherence to surveillance protocols and further research into novel therapies and multimodal regimens are essential.
• Optimizing treatment algorithms through clinical trials is necessary to enhance outcomes for hepatocellular carcinoma patients.
• Advancements in surgical techniques, interventional radiology, and transplantation are transforming early-stage HCC management.